© JULY/AUGUS T 2017, ASSOCIATION OF CORPORATE COUNSEL 13
2017 TOP 10 30-SOMETHING
PARK, NORTH CAROLINA
It’s easy to drive to work when your ultimate goal is to feed the world’s growing population.
And with 10 billion people projected by 2050, it relies on human innovation like Bayer’s
Crop Science Division to help grow the food needed to feed the world.
Jocelyn Shaw provides product support for the North American region. Her team
includes a product steward, regulatory specialists, financial analysts, and scientists, while
she serves as counsel as they work to bring innovative products to market. Bayer invests on
average $US1 billion in R&D to create new, innovative, and trusted solutions for sustainable
Shaw’s role is varied. Because so much of crop protection and biotechnology products
involve IP rights, she helps coach the company’s scientists before they collaborate with
third parties. This spring, she worked with product development leadership to develop and
acquire drone technology. She provided advice on the evolving regulatory landscape, including FAA regulations and the certifications necessary to operate drones to conduct research
on plant characteristics in the field. She routinely manages and counsels clients on sensitive
production channel issues, negotiates licensing agreements with key partners, competitors,
and customers, and provides legal guidance on marketing strategy and the development of
Bayer’s next generation products.
Shaw really enjoys being a part of the innovation and technology that is transforming
the agricultural industry. She especially enjoys opportunities to interact with customers,
including one trip to Puerto Rico with some of Bayer’s top soybean licensees to see some of
their latest field tests. “Bayer has a true focus on the customer and does a good job cultivating relationships with our customers that help us uniquely understand their needs and create technologies to fill those needs. It’s very rewarding to be a part of this,” she explains.
Shaw, like all in-house lawyers, is especially attuned to risk. She doesn’t see Bayer’s
crops failing or a rival company as the biggest source of risk. Instead, it’s the lack of acceptance among the general public when it comes to genetically modified foods and crop
protection products. “More than 90 percent of the population has no connection to agriculture, which creates an environment where activists can cultivate fear about modern agriculture technologies in the minds of consumers,” she explains. It’s an essential part of her role
to advocate for Bayer’s technologies and the benefits they bring. After all, she adds, it takes
over 10 years of research, testing, and regulatory approval and registration before a product
gets to market.
In fall 2014, she traveled to Bayer’s headquarters outside Cologne, Germany. She
worked with her European counterparts to help create an anticorruption assessment, and
then helped roll out the training. She says the biggest benefit was forging relationships with
her peers in other regions and working toward the common goal of Bayer: feeding the
She continues to work closely with her global colleagues and has routinely presented
and taken part in global legal meetings in Europe, including leading presentations on the
regulatory status in North America of new biotech breeding techniques and providing guidance on US export control law. 30